Effects of the Rebozo Technique During Active Labor on Labor Pain and Labor Duration in Primiparous Women
Rebozo Techniq
1 other identifier
interventional
120
1 country
1
Brief Summary
Study Description Childbirth is a physiological process often accompanied by severe pain and prolonged labor, which may negatively affect maternal well-being and increase the likelihood of obstetric interventions. Non-pharmacological approaches that support physiological labor are recommended as part of evidence-based intrapartum care. The Rebozo technique is a traditional midwifery intervention involving rhythmic pelvic mobilization using a woven cloth to promote maternal comfort, facilitate fetal descent and rotation, and improve labor progression. This single-center, parallel-group randomized controlled trial aims to evaluate the effectiveness of the Rebozo technique on labor pain intensity and labor duration among primiparous women during the active phase of labor. Eligible participants will be randomly assigned in a 1:1 ratio to either the intervention group, receiving the Rebozo technique in addition to routine intrapartum care, or the control group, receiving routine intrapartum care alone. The primary outcomes are labor pain intensity, assessed using the Visual Analog Scale (VAS), and labor duration, measured from the active phase of labor (6 cm cervical dilatation) until birth. The findings are expected to provide evidence regarding the effectiveness, feasibility, and clinical applicability of the Rebozo technique as a safe, low-cost, non-pharmacological intervention to support physiological childbirth and improve maternal intrapartum outcomes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Dec 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2025
CompletedFirst Submitted
Initial submission to the registry
August 3, 2026
CompletedFirst Posted
Study publicly available on registry
August 12, 2026
CompletedAugust 12, 2026
August 1, 2026
5 months
August 3, 2026
August 6, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Labor Pain Intensity Assessed Using the Visual Analog Scale for Pain
Labor pain intensity was assessed using the 10-cm Visual Analog Scale for Pain, ranging from 0 (no pain) to 10 (worst imaginable pain). Higher scores indicate greater pain intensity and therefore a worse outcome. Scores were recorded immediately before and immediately after completion of the Rebozo intervention. The control group was assessed at corresponding time points.
Immediately before the intervention and immediately after its completion, approximately 15 minutes after the baseline assessment during active labor.
Secondary Outcomes (1)
Duration of the Active Phase of Labor
From the first documentation of 6 cm cervical dilatation until birth, assessed up to 24 hours.
Study Arms (2)
Rebozo Group
EXPERIMENTALParticipants allocated to this group received the Rebozo technique in addition to routine intrapartum care. The Rebozo technique was applied during the active phase of labor using a standardized protocol consisting of three sessions of approximately five minutes each.
Control Group
ACTIVE COMPARATORParticipants allocated to the control group received routine intrapartum care according to the institutional labor management protocol. No Rebozo intervention was administered.
Interventions
The Rebozo technique is a standardized non-pharmacological intervention performed using a traditional woven cloth to provide rhythmic pelvic mobilization during the active phase of labor. The intervention was administered in three sessions of approximately five minutes each by a trained researcher in addition to routine intrapartum care.
Routine intrapartum care was provided according to the institutional clinical protocol and included maternal and fetal monitoring, assessment of labor progress, supportive midwifery care, and obstetric management when clinically indicated.
Eligibility Criteria
You may qualify if:
- Primiparous women
- Aged 18-35 years
- Singleton pregnancy
- Cephalic fetal presentation
- Gestational age between 37 and 42 completed weeks
- Spontaneous onset of labor
- Cervical dilatation of 6 cm (active phase of labor)
- No contraindication to vaginal birth
- Able to communicate in Turkish
- Provided written informed consent
You may not qualify if:
- Multiple pregnancy
- Non-cephalic fetal presentation
- Previous uterine surgery
- Pregnancy complications requiring emergency obstetric intervention
- Planned cesarean birth
- Maternal or fetal conditions requiring immediate delivery
- Refusal or withdrawal of informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Başakşehir Çam and Sakura City Hospital
Istanbul, 34408, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Yeliz YILDIRIM VARIŞOĞLU, Assoc. Prof.
Istanbul University
- PRINCIPAL INVESTIGATOR
Gamze ÇERÇİNLİ, Midwife
Başakşehir Çam & Sakura City Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Masking Details
- Due to the nature of the intervention, blinding of participants and care providers was not feasible. Outcome measures were collected using standardized procedures.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assoc. Prof.
Study Record Dates
First Submitted
August 3, 2026
First Posted
August 12, 2026
Study Start
December 1, 2024
Primary Completion
May 1, 2025
Study Completion
June 30, 2025
Last Updated
August 12, 2026
Record last verified: 2026-08
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, CSR
- Time Frame
- Beginning 6 months after publication and ending 5 years after publication.
- Access Criteria
- Access will be provided to qualified researchers whose proposed use of the data has been approved by the corresponding author following review of a scientifically sound research proposal.
Individual participant data (IPD) that underlie the results reported in the publication, after de-identification, will be made available upon reasonable request to the corresponding author. Data will be shared with qualified researchers for scientifically sound research purposes after approval of a methodologically appropriate research proposal. Supporting documents, including the study protocol and statistical analysis plan, may also be made available. Data will be available beginning six months after publication and ending five years after publication.